Samsara Biocapital, Llc
Source: SEC Form 13F · as of Mar 2026Samsara Biocapital, Llc holds 14 biotech & pharma companies tracked by BioSniper, totaling $704.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$704.9M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Scholar Rock Holding Corp (SRRK)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| SRRKScholar Rock Holding Corp | 6,897,652 | $339.1M |
| ALMSALUMIS INC. | 6,345,219 | $139.8M |
| KLRSKalaris Therapeutics, Inc. | 12,948,081 | $74.7M |
| NGNENeurogene Inc. | 1,717,127 | $34.6M |
| IVAInventiva S.A. | 5,194,805 | $28.8M |
| STROSUTRO BIOPHARMA, INC. | 1,062,872 | $26.5M |
| JBIOJade Biosciences, Inc. | 968,798 | $13.6M |
| AQSTAquestive Therapeutics, Inc. | 2,500,000 | $10.4M |
| XFORX4 Pharmaceuticals, Inc | 1,832,566 | $7.6M |
| UPBUpstream Bio, Inc. | 736,047 | $6.6M |
| ABVXAbivax SA | 56,581 | $6.3M |
| AGMBAgomAb Therapeutics NV | 600,000 | $6.3M |
| CHRSCoherus Oncology, Inc. | 3,428,571 | $5.8M |
| PVLAPALVELLA THERAPEUTICS, INC. | 38,432 | $4.8M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.